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SEVERITY OF ANXIETY AND WORK-RELATED
OUTCOMES OF PATIENTS WITH ANXIETY DISORDERS
Steven R. Erickson, PharmD.,1 Sally Guthrie, PharmD.,1 Michelle VanEtten-Lee, Ph.D.,2 Joseph Himle, Ph.D.,3
Jody Hoffman, Ph.D.,4 Susana F. Santos, PharmD.,5 Amy S. Janeck Ph.D.,6 Kara Zivin Ph.D.,7,8 and
James L. Abelson, M.D.7
Background: This study examined associations between anxiety and work-
related outcomes in an anxiety disorders clinic population, examining both
pretreatment links and the impact of anxiety change over 12 weeks of treatment
on work outcomes. Four validated instruments were used to also allow
examination of their psychometric properties, with the goal of improving
measurement of work-related quality of life in this population. Methods: Newly
enrolled adult patients seeking treatment in a university-based anxiety clinic
were administered four work performance measures: Work Limitations
Questionnaire (WLQ), Work Productivity and Activity Impairment Ques-
tionnaire (WPAI), Endicott Work Productivity Scale (EWPS), and Functional
Status Questionnaire Work Performance Scale (WPS). Anxiety severity was
determined using the Beck Anxiety Inventory (BAI). The Clinical Global
Impressions, Global Improvement Scale (CGI-I) was completed by patients to
evaluate symptom change at a 12-week follow-up. Two severity groups
(minimal/mild vs. moderate/severe, based on baseline BAI score) were compared
to each other on work measures. Results: Eighty-one patients provided complete
baseline data. Anxiety severity groups did not differ in job type, time on job, job
satisfaction, or job choice. Patients with greater anxiety generally showed lower
work performance on all instruments. Job advancement was impaired for the
moderate/severe group. The multi-item performance scales demonstrated better
validity and internal consistency. The WLQ and the WPAI detected change with
symptom improvement. Conclusion: Level of work performance was generally
associated with severity of anxiety. Of the instruments tested, the WLQ and the
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INTRODUCTION
Anxiety disorders are common[1] and costly,[2] with
lost work-productivity contributing substantially to
their total costs and creating dependence on govern-
mental support.[3–6] They impact work performance
by reducing employment opportunities, work funct-
ioning, and attendance. Pharmacological treatments
can reduce symptoms and improve function, but
also cause side effects that can undermine functional
improvement.[7] There is growing consensus that in
order to optimize treatments, outcome studies
should measure both symptomatic and functional
recovery, including general quality of life and work
performance.[8]
Work function studies in patients with panic disorder
have documented high unemployment and low health-
related quality of life; and even those with jobs report
low work-productivity.[9,10] Feeling disabled at work is
associated with low ‘‘Quality of Well-Being.’’[11] Most
anxiety studies have focused on panic, so information
on other anxiety disorders is limited, though anxiety
diagnoses in general have been associated with
impaired work performance.[12–14] An epidemiological
study[3,15] also documented a narrowed range of
employment opportunities, difficulty changing jobs,
and restrictions in hours worked among people with
anxiety disorders.
Integrating existing literature is difficult due to the
wide range of instruments used, making comparisons
across studies and across disorders difficult.[16] Numer-
ous work-function instruments have been validated
over the past decade.[17,18] Most can be used across
disorders, but they vary in aspects of work function
measured, and some may be better than others in
identifying work impairment and tracking improve-
ment for particular disorders.
This study examined self-reported work-productivity
in adult patients with anxiety disorders, using four
major instruments in wide-spread use at its inception
(Work Limitations Questionnaire (WLQ), Endicott
Work Productivity Scale (EWPS), Work Productivity
and Activity Impairment Questionnaire (WPAI),
and Work Performance Scale of the Functional Status
Questionnaire (WPS)). Goal one was to examine
the impact of anxiety severity on work-related out-
comes in an anxiety specialty clinic population. Goal
two was to examine psychometric properties (sensitiv-
ity, internal reliability, and construct validity) of the
four instruments and to assess their relative suitability
for use in this population.
METHODS
DESIGN AND SAMPLE
We measured self-reported health-related quality of life and work-
related outcomes for patients seeking anxiety treatment, prior to
treatment and at 12-week follow-up. Patients seeking evaluation at
the University of Michigan Anxiety Disorders Program between
February 2002 and June 2005 were recruited and offered a $20
incentive to participate. Entry criteria required presence of an anxiety
disorder (generalized anxiety, panic, obsessive–compulsive disorder,
or social phobia) in patients who were adult (18 years old) English
speakers who worked outside the home at least 20 hr per week for pay.
Patients with schizophrenia, substance abuse, dementia, or suicidal
ideation were excluded. The study was IRB approved and all subjects
provided written, informed consent. Diagnoses were established on
the basis of a two-hour clinical interview and consensus review by an
interdisciplinary team.
DATA COLLECTION
Data were obtained from questionnaires and medical records.
A work survey was mailed to all new patients as a single document
containing the four work-productivity questionnaires (106 items),
along with the consent document, a postage-free return envelope, and
clinical questionnaires assessing symptom profiles and severity.
Subjects were asked to return completed materials by mail before
evaluation, but were also permitted to complete them at initial visit.
Twelve weeks later, subjects with complete baseline data were mailed
a follow-up packet containing only quality of life and work
performance instruments.
WORK MEASURES
The WLQ[19] covers a two-week time period with 25 items and 4
subscales: (1) ‘‘time management,’’ (2) ‘‘physical demands,’’ (3)
‘‘mental–interpersonal demands,’’ and (3) ‘‘output demands.’’ Sub-
scale scores range from 0 (greatest impairment) to 100 (highest
possible performance). The WPAI Questionnaire (WPAI, General
Version) describes work, classroom, and activity impairment as a
result of disease and/or treatment[20,21] using four subscales: (1)
‘‘percent activity impairment,’’ (2) ‘‘percent work time missed,’’ (3)
‘‘percent impairment while working,’’ and (4) ‘‘final overall work
impairment.’’ Scores range from 0 to 100% (complete impairment).
The EWPS measures work-productivity[22] in various job settings,
including self-employment, using 25 items (0–4 scale) to quantify
work-related behaviors, feelings, or attitudes over the past week. Item
scores are summed to produce a total score with higher values
reflecting greater impairment. The Functional Status Questionnaire
WPS measures amount of work performed, time worked and breaks
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per shift, hours worked, accuracy and carefulness of work, health-
related job changes, and fear of losing job due to health.[23] It uses six
items scored on a five-point scale, with low scores reflecting
impairment.
Additional job-related questions were included on an investi-
gator-formulated questionnaire to measure overall job satisfaction,
length of time on the job, likelihood of choosing the same job
again, and type of job (International Standard Classification of
Occupations, 1988). Subjective ratings of ‘‘strongly agree’’ to
‘‘strongly disagree’’ were used to assess the influence of anxiety on
job choice and job advancement.[24,25] Number of work hours missed
in the preceding week was included to assess absenteeism.
SEVERITY AND CLINICAL CHANGE MEASURES
The Beck Anxiety Inventory (BAI)[26] was obtained at baseline
only, providing a general measure of anxiety severity applicable across
diagnoses. Scores can range from 0 to 63 and are categorized as
minimal (0–7), mild (8–15), moderate (16–25), and severe (26–63).
Clinical improvement in disease severity over the 12-week follow-up
was quantified using the Clinical Global Impressions, Global
Improvement Scale (CGI-I), patient version.[27]
ADDITIONAL MEASURES
The SF-36 Health Survey Version 2 (SF-36) was used to assess
health-related quality of life.[28] It measures self-perceived concepts
of physical functioning, role limitations due to physical health
problems, bodily pain, general health, vitality, social function, role
limitations due to emotional problems, and mental health. The ‘‘role-
emotion’’ and ‘‘role-physical’’ scales include references to work, and
together they function as a broad descriptor of role-functioning. The
Sheehan Disability Scale (SDS)[29] provided another general measure
of role functioning (3 Likert measures of symptom interference with
work, social life, and family/home life).
ANALYSES
The BAI was used to dichotomize patients into high (BAI scores of
16–63) and low (BAI 0–15) severity groups. The two groups were
compared on demographic, job, and work-related data using t-tests
and w2 tests. Effect sizes for differences between groups were
calculated using Cohen’s d.
Patients were separately dichotomized using CCG-I scores (after
12 weeks of treatment) into those who perceived worsening or no
change in their anxiety and those who perceived improvement.
Separate paired t-tests were used for each group to determine
whether the group improved significantly from baseline to follow-up
on work-productivity measures. Effect sizes for differences in
the change in scale scores between groups were calculated using
Cohen’s d.
Internal consistency of all multi-item subscales for the WLQ,
EWPS, and WPS instruments was assessed using Cronbach’s a.
Construct validity was assessed using Spearman’s rank-order correla-
tion, comparing work-productivity scale scores and the role-
functioning scales of the SF-36 and the work-performance scale of
the SDS.
Missing data from individual questionnaires were handled accord-
ing to the recommendations of the developers of each questionnaire.
Generally, if more than half of the item responses of a particular scale
were missing, the scale score was not calculated. For all analyses,
differences were considered significant at Pr0.05.
RESULTS
Because of personnel problems, active recruitment
was underway during approximately half of the
evaluation clinics conducted over the 3-year recruit-
ment span. Because of manpower limitations, not all
patients at each evaluation clinic could be appro-
ached for consent. We estimate that fewer than 300
of a potential pool of 717 patients were invited
to participate, and a proportion of these did not
meet age or diagnosis entry criteria. Of those eli-
gible, 159 signed informed consent and 115 met the
work requirement at the time of questionnaire comple-
tion. Eighty-one of these provided complete baseline
data, and 50 provided both baseline and follow-up data.
CHARACTERISTICS OF THE TWO
SEVERITY GROUPS
Of the 81 patients included in baseline analyses, 41
were categorized by the BAI as minimal-to-mild in
severity and 40 were categorized as moderate-to-
severe. Group demographic, illness, and health status
data are presented in Table 1. Groups did not differ in
age, race, education, anxiety diagnosis, or physical-
related health status. The high anxiety group contained
more females and demonstrated lower mental-related
health status, role physical, and role emotional scale
scores, and greater Sheehan disability compared to the
low anxiety group.
On work-related measures, the groups did not differ
in the type of job, length of time on job, satisfac-
tion with job, or job choice (Table 2). However,
significantly more patients in the high anxiety group
indicated that anxiety impaired their ability to advance
in their job.
Group comparisons on work-performance scale scores
are presented in Table 3. The high anxiety group was
significantly more impaired than the low anxiety group
on the WPS, the WPAI ‘‘percent impairment while at
work,’’ ‘‘overall work impairment,’’ ‘‘percent activity
impairment’’ subscales, and the WLQ ‘‘output demands,’’
‘‘physical demands,’’ and ‘‘interpersonal demands’’ sub-
scales. Effect sizes were generally moderate, ranging
from 0.36 to 0.73, except for a large anxiety severity
effect (0.87) on WPAI-Percent Activity Impairment Due
to Health. Three of the four WPAI scores had effect
sizes over 0.7, while the four WLQ scales effect sizes
were 0.68 or less.
Of the 50 patients with both baseline and follow-up
data, 38 improved and 12 did not change or worsened
(Table 4). The group without symptom improvement
showed no changes on any work performance measures.
The symptomatically improved group showed mixed
results. Many measures showed no change, but three of
the four scales of the WPAI (‘‘percent impairment while
working,’’ ‘‘final overall impairment due to health,’’
and ‘‘percent activity impairment due to health’’)
improved significantly in this group. They also improved
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TABLE 1. Comparison of demographic and anxiety variables between patients with minimal/mild anxiety to those with
moderate/severe anxiety
Variable BAI minimal-to-mild anxiety (n 5 41) BAI moderate-to-severe anxiety (n 5 40) P-value
Age-years, mean (SD) 37.5 (12.2) 34.2 (9.8) 0.17
Gender-frequency (%)
Female 20 (48.8) 30 (75.0) 0.02
Male 21 (51.2) 10 (25.0)
Race-frequency (%)
Caucasian 39 39 1.0
Minority 1 0
Education-years, mean (SD) 15.1 (2.5) 14.5 (1.5) 0.19
BAI Score, mean (SD) 9.2 (4.5) 26.9 (7.6) o0.001
Type of anxiety disorder 0.3
OCD 2 (5.9) 3 (10.3)
Panic w/agor 1 (2.9) 6 (20.7)
Social phobia 7 (20.6) 4 (13.8)
GAD 4 (11.8) 7 (24.1)
Anxiety DO NOS 2 (5.9) 0 (0.0)
Specific phobia 4 (11.8) 1 (3.4)
Hypochondriasis 1 (2.9) 1 (3.4)
Body dysmorphic dis 2 (5.9) 1 (3.4)
Trichotillomania 2 (5.9) 0 (0.0)
Panic w/o agor 4 (11.8) 3 (10.3)
MDD 5 (14.7) 3 (10.3)
SF-36 scale scores
PCS 56.9 (8.8) 53.3 (9.9) 0.1
MCS 38.1 (14.1) 28.2 (10.5) 0.001
Role physical 50.7 (9.0) 44.3 (12.7) 0.004
Role emotional 40.3 (12.8) 31.0 (12.6) o0.001
Sheehan disability index
Work Life 2.8 (2.6) 4.4 (3.1) 0.01
Social Life 3.8 (3.1) 6.0 (2.9) 0.002
Home Life 2.5 (2.7) 4.5 (3.3) 0.004
Beck Anxiety Index: higher score indicates more severe anxiety. SF-36 Summary Scale Scores: higher score indicated better functioning. PCS,
Physical Component Summary scale; MCS, Mental Component Summary Scale; Sheehan Disability Index: higher scale value indicates poorer
performance, range from 0, not impaired to 10, very severely impaired.




anxiety (n 5 41)
Moderate-to-severe
anxiety (n 5 40) P-value
Job description 0.19
Secretarial 2 (4.9) 5 (12.2)
Agricultural 1 (2.4) 0 (0.0)
Skilled trades 3 (7.3) 2 (4.9)
Management 5 (12.2) 3 (7.3)
Sales 1 (2.4) 5 (12.2)
Professional 20 (48.8) 12 (29.3)
Other 8 (22.0) 13 (34.1)
Satisfaction with job
If you were looking for job, how likely would
it be to take the same job you have now
3.6 (1.4) 3.6 (1.2) 0.77
Satisfaction with current job 3.0 (1.3) 3.1 (1.2) 0.65
Length of time on current job-years, mean (SD) 6.0 (7.9) 4.7 (4.7) 0.40
Job choice influenced by anxiety 4.4 (1.1) 4.0 (1.3) 0.15
If not for anxiety, I would have a different job 4.2 (1.3) 4.0 (1.4) 0.56
Anxiety prevents job advancement 4.0 (1.4) 3.3 (1.6) 0.048
If looking for job, likelihood of taking same job: 1, not likely at all; 5, very likely. Satisfaction with job: 1, very satisfied; 5, very unsatisfied; Scale
ranges from 1, strongly agree to 5, strongly disagree.
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significantly on two of the four WLQ subscales (‘‘output
demands’’ and ‘‘mental interpersonal’’). Effect sizes for
change score comparisons between groups were generally
moderate (Table 4). Large effect sizes were observed for
the WPAI-Percent Activity Impairment due to Health,
the WLQ-Output Demands, and the WLQ Mental-
Interpersonal scale comparisons.
The instruments all had good internal consistency,
with Cronbach’s as as follows: EWPS 5 0.95,
WPS 5 0.82, WLQ ‘‘time management’’ 5 0.91, ‘‘phy-
sical demands’’ 5 0.97, ‘‘mental interpersonal’’ 5 0.92,
and ‘‘output demands’’ 5 0.93. Construct validity was
assessed by correlating subscales of the work-produc-
tivity measures with the role–emotional and role–phy-
sical functioning scales of the SF-36, and with the SDS
work scale (Table 5). The SF-36 role–emotional and
the SDS work impairment scales were significantly
correlated with all but one of the work-performance
instruments and subscales. These correlations were
moderate-to-good (r 5 .4–.8). The WLQ ‘‘physical
demands’’ subscale was significantly correlated with
the SF-36 ‘‘role–emotional’’ score.
DISCUSSION
These data confirm that patients presenting for
treatment in an academic anxiety disorders program
have substantial work impairment and that greater work
performance impairment is reported by those with
higher anxiety severity. Similar relationships have been
documented in other studies, for both depression and
anxiety, examining work performance and attendance,
using the WLQ, the Stanford Presenteeism Scale, and
two single item scales measuring presenteeism days and
inefficiency days.[12] The presence of an anxiety disorder
is also associated with less accomplished at work.[3]
Based on the WLQ, anxiety has a significant influence
on interpersonal relationships at work as well as work
output. The general measure WPAI confirms this
association with significant findings based on Overall
Work Impairment due to Health and Percent Impair-
ment While at Work due to Health scale scores.
The WLQ and the WPAI demonstrated the most
consistent psychometric properties of the four instruments
examined. Both provide multiple subscales and most
TABLE 4. Change in WPS scores based on patient perceived progress in illness over twelve weeks
Perceived improved (n 5 38) Perceived no change or worsening (n 5 12)
Variable Mean (SD) change P-value Mean (SD) Change P-value Effect size
WPS 0.14 (0.78) 0.28 0.21 (0.44) 0.14 0.49
Endicott 3.13 (13.9) 0.17 6.45 (12.5) 0.12 0.71
WPAI percent work time missed 0.04 (0.19) 0.26 0.01 (0.05) 0.44 0.19
WPAI percent impairment while working 0.18 (0.32) 0.002 0.01 (0.22) 0.89 0.69
WPAI final overall work impairment 0.15 (0.33) 0.01 0.02 (0.21) 0.72 0.61
WPAI percent activity impairment due to health 0.12 (0.32) 0.03 0.11 (0.19) 0.08 0.87
WLQ – time management 7.38 (29.1) 0.12 2.10 (25.27) 0.78 0.35
WLQ – output demands 10.0 (24.6) 0.01 8.75 (18.60) 0.13 0.86
WLQ – physical demands 3.23 (33.66) 0.55 3.79 (58.19) 0.83 0.01
WLQ – mental interpersonal 12.02 (22.4) 0.002 8.80 (17.48) 0.11 1.03
NA, could not be calculated.
TABLE 3. Comparison of Work-Performance Questionnaires based on the BAI
Work-Performance Questionnaire and scale scores
Minimal-to-mild
anxiety (n 5 41)
Moderate-to-severe
anxiety (n 5 40) P-value Effect size
EWPS 24.3 (17.3) 32.6 (19.2) 0.05 0.45
WPS score 4.3 (0.7) 3.8 (0.9) 0.006 0.62
Work-Performance Activity Index – General Questionnaire
Percent work time missed due to health 0.07 (0.2) 0.16 (0.2) 0.11 0.45
Percent impairment while at work due to health 0.24 (0.3) 0.45 (0.3) 0.003 0.70
Final overall work impairment due to health 0.28 (0.3) 0.50 (0.3) 0.003 0.73
Percent activity impairment due to health 0.25 (0.2) 0.47 (0.3) 0.001 0.87
WLQ
Time management 25.4 (28.5) 35.3 (26.8) 0.11 0.36
Output demands 21.3 (25.6) 34.8 (27.1) 0.03 0.51
Physical demands 11.8 (24.9) 30.3 (32.6) 0.005 0.64
Mental interpersonal demands 27.1 (21.8) 37.4 (20.9) 0.03 0.48
Endicott: 0, best performance; 4, poorest performance; Work-Performance Scale: 1, poorer performance; 5, best performance; WPAI: higher scale
value indicates poorer performance, Work Limitations Questionnaire: higher scale value indicates poorer performance.
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demonstrated acceptable validity. For example, there were
significant differences on WLQ ‘‘output demands,’’
‘‘physical demands,’’ and ‘‘mental interpersonal demands’’
scales based on comparison by anxiety severity, with better
work performance associated with lower anxiety. Symp-
tom severity effects on WPAI measured impairment have
also been reported by others.[12] Our moderate-to-large
effect sizes for all comparisons based on severity support
the validity of these scales.
We did not find anxiety group differences in WPAI
‘‘percent work time missed due to health’’ and the
WLQ ‘‘physical demands’’ scale. This suggests that
high anxiety may not lead to absences as often as
physical illnesses, though impaired functioning while at
work was clearly present in this group.
The WLQ demonstrated acceptable internal con-
sistency. The WPAI uses single item scales so internal
consistency is not relevant. Two of four WLQ scales
(‘‘output demands’’ and ‘‘mental interpersonal’’) and
three of four WPAI scales (all but ‘‘percent time missed
due to health’’) demonstrated sensitivity to changes in
perceived clinical condition, with significant improve-
ment in work function over the twelve week follow-up
period in patients who perceived improvement in their
disorder. Effect sizes for improvement group compar-
isons on symptom change scores were moderate to
large, further confirming their ability to detect change.
The WPS and the EWPS did not function as
effectively as the WLQ and the WPAI. Both showed
good internal consistency, and the WPS was better able
to distinguish work performance based on anxiety
severity than the EWPS; but neither instrument was
sensitive to symptom change in patients who improved,
based on change within group comparisons.
Based on correlation analyses with role functioning
and SDS-work scales, all instruments tested were
valid in this anxious population. However, to be useful
in comparative studies or clinical practice, instru-
ments should be able to discriminate between various
levels of disease severity. The WPAI and WLQ
scales demonstrated this ability; the EWPS and WPS
did not. The WPAI provides a good general assessment
of time missed from work and percent impairment using
only 6 questions, which tracked both anxiety severity and
improvement with treatment. It provides a good, brief
instrument when a general measure is sufficient. When
more detailed, domain specific work performance data is
needed, the 25 item WLQ can be used, alone or in
conjunction with the WPAI., to provide a more
comprehensive picture of work functioning.
LIMITATIONS
We enrolled only a subset of patients seeking
treatment and do not have good data to document how
representative these were of our total clinic population,
though we have no evidence of any systematically biasing
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from an academic anxiety specialty clinic. Further work
is needed to determine the generalizability of our results.
We included only patients with anxiety disorders and
did not document the presence of physical illness. We
therefore cannot evaluate the impact of concurrent
physical illness on work performance in these anxious
patients, and cannot compare them to patients with
other psychiatric disorders. We also only included
patients who had jobs outside their homes. Since
anxiety patients have high rates of nonparticipation in
the work force,[3] we likely underestimated the true
impact of anxiety on work function.
Test-retest reliability was not assessed as part of the
psychometric analysis. We were focused on the associa-
tion of clinical outcomes with work performance, so we
used a 12 week follow-up period to capture significant
clinical improvement, and predicted clinically-related
change in work performance measures. Assessment of
test-retest stability would require a different design and
a much shorter reassessment period.
CONCLUSION
Work performance was measured using four work
performance instruments in a clinic sample of anxiety
disorder patients. Greater illness severity was associated
with greater impairment in work-performance. Work
performance improved with symptom improvement. For
this population, we recommend the WPAI as a brief,
general measure of work function and the WLQ when a
more detailed, domain specific instrument is needed, as
both showed good psychometric performance, sensitivity
to illness severity, and sensitivity to change with
symptomatic improvement.
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